TrialSchizophrenia research2014

A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.

Brenda Vincenzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.